2024-03-28T16:32:23Z
http://repoint.unil.ch/oaiprovider/
oai:serval.unil.ch:BIB_466AFA1A39D5
2024-03-23T02:18:40Z
serval:BIB_466AFA1A39D5
CYP2D6 and ABCB1 genetic variability: influence on paroxetine plasma level and therapeutic response.
10.1097/FTD.0b013e31817d6f5d
18641553
000258114900011
Gex-Fabry
M.
author
Eap
C.B.
author
Oneda
B.
author
Gervasoni
N.
author
Aubry
J.M.
author
Bondolfi
G.
author
Bertschy
G.
author
article
2008-08
2008-08
Therapeutic drug monitoring
0163-4356
0163-4356
journal
30
4
474-482
Adolescent
Adult
Aged
Algorithms
Analysis of Variance
Antidepressive Agents, Second-Generation/blood
Antidepressive Agents, Second-Generation/therapeutic use
Cytochrome P-450 CYP2D6/genetics
Depressive Disorder, Major/blood
Depressive Disorder, Major/drug therapy
Female
Gas Chromatography-Mass Spectrometry
Genetic Variation
Humans
Linear Models
Male
Middle Aged
P-Glycoprotein/genetics
P-Glycoproteins
Paroxetine/blood
Paroxetine/therapeutic use
Phenotype
Psychiatric Status Rating Scales
Young Adult
eng
60_published
peer-reviewed
Publication types: Journal Article ; Research Support, Non-U.S. Gov't
Publication Status: ppublish